ArticleBritish journal of pharmacology2017

COX-2-selective inhibitors celecoxib and deracoxib modulate transient receptor potential vanilloid 3 channels.

Stefan Spyra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.